Skip to content
★ Sign in to follow
SR

Susan Richards Windham-Bannister

Aridis Pharmaceuticals, Inc.Cambridge Bancorp
Total declarations
2
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 15 Jun 2023 for Aridis Pharmaceuticals, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Susan Richards Windham-Bannister: trading record in brief

Filings by Susan Richards Windham-Bannister span 2 companies, the busiest being Aridis Pharmaceuticals, Inc. and Cambridge Bancorp. In total, 2 filings cover trades dated from 20 June 2018 to 5 June 2023.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 15 June 2023, the filings show an option exercise in Aridis Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Susan Richards Windham-Bannister

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total

2 of 2 declarations